InvestorsHub Logo

UFO

Followers 12
Posts 1104
Boards Moderated 0
Alias Born 03/27/2003

UFO

Member Level

Re: None

Monday, 09/18/2017 1:53:25 PM

Monday, September 18, 2017 1:53:25 PM

Post# of 7536
Zynex Continues Fight Against Opioid Abuse and Expands Its Arsenal of Pain Relief Products
PR Newswire
LONE TREE, Colo., Sept. 18, 2017
LONE TREE, Colo., Sept. 18, 2017 /PRNewswire/ -- Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics.  The company continues to introduce several new products to its product portfolio in its efforts to address the pain and rehabilitation markets and the current opioid epidemic.
Given American's current crisis with opioid addiction, Zynex is committed to providing health care professionals a variety of prescription-strength options without side-effects. This has never been more necessary than it is today considering the staggering statistics. 
Pain impacts the lives of more Americans than diabetes, heart disease and cancer combined.
Pain is the leading cause of disability and the most common reason American's seek health care is because they are seeking treatment for acute or chronic pain.
1 in every 4 Americans (76.2 million people), suffer with pain that lasts longer than 24 hours.
Approximately 25.3 million adults struggle with chronic pain, pain every day that has been present for more than 3 months.
If pharmaceuticals such as opioids continue to be used as the first line of defense America will continue to see a rise in opioid misuse, addiction and drug-related deaths.
Aware of the current issues, Zynex has a dedicated team working to expand the product line beyond electrotherapy alone. Zynex has added new products such as JetStream Hot/Cold Therapy, Aspen LSO Backbracing and Comfortrac cervical traction, all products targeted at treating acute as well as chronic pain without side-effects.  
Zynex is committed to making prescription strength drug-free options more accessible to patients and easier for physicians to prescribe as a first line defense rather than prescribing opioid pharmaceuticals.
Thomas Sandgaard, Founder and CEO commented: "Our prescription-strength NexWave device is already available nationwide and I am excited that we are now able to offer traction, low back support and cold/hot therapy as an effective alternative for physicians to prescribe for patients with severe pain.
I strongly believe that any effort to provide opioid free treatment can improve the lives of millions of Americans living with pain, slow down the too frequent path to addiction and hopefully save many lives. We are currently experiencing a horrific epidemic in this country and I am committed to be part of a healthy solution to the problem.   
As we continue to expand our sales force and increase our presence across the country, all of these products will become more accessible. In an effort to provide more details about Zynex prescription-strength products, we are developing a National Webcast service designed to educate health care providers on our product line and the ease of prescribing. Our EZ-Rx program makes it easy for physicians everywhere in the U.S. to offer drug-free solutions to their efforts of pain management."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ZYXI News